What is WIPO Standard ST.26 and how does it relate to patent applications?
WIPO Standard ST.26 is an international standard that defines the format and content requirements for nucleotide and amino acid sequence listings in patent applications. It was developed by the World Intellectual Property Organization (WIPO) to standardize the presentation of sequence information across different patent offices globally. According to MPEP 2412.02(a), WIPO Standard ST.26 is incorporated…
Read MoreHow are residues represented in sequence enumerations according to WIPO Standard ST.26?
WIPO Standard ST.26 specifies two ways to represent residues in sequence enumerations: Individual representation: Each residue is represented by a name, abbreviation, symbol, or structure. For example, “HHHHHHQ” or “HisHisHisHisHisHisGln”. Shorthand formula: Multiple residues are represented by a condensed notation. For example, “His6Gln”. As stated in MPEP 2412.02(a): “WIPO Standard ST.26 specifies that ‘enumeration of…
Read MoreWhat does “enumeration of its residues” mean in patent applications?
“Enumeration of its residues” refers to the disclosure of a nucleotide or amino acid sequence in a patent application. According to MPEP 2412.02(a), it means: “disclosure of a nucleotide or amino acid sequence in a patent application by listing, in order, each residue of the sequence, where the residues are represented in the manner as…
Read MoreWhen did the new requirements for nucleotide and amino acid sequence disclosures in patent applications take effect?
The new requirements for nucleotide and amino acid sequence disclosures in patent applications took effect on July 1, 2022. This is clearly stated in MPEP 2412.02(a): “[Editor Note: This section is applicable to all applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR…
Read More